Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
12/10/2009 | WO2009149185A2 Dual variable domain immunoglobulins and uses thereof |
12/10/2009 | WO2009148330A1 Compositions and methods for improving plants |
12/10/2009 | WO2009147742A1 Sirna of human osteopontin |
12/10/2009 | WO2009146556A1 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof |
12/10/2009 | WO2009122051A3 Method, process, and kit for cancer diagnosis, prognosis and aftercare |
12/10/2009 | WO2009117698A3 Methods of rna amplification in the presence of dna |
12/10/2009 | WO2009114487A9 Use of sirna to achieve down regulation of an endogenous gene in combination with the use of a sense construct to achieve expression of a desired polynucleotide |
12/10/2009 | WO2009111440A3 Methods and compositions for reducing nucleotide impurities |
12/10/2009 | WO2009074990A3 Rtp801l sirna compounds and methods of use thereof |
12/10/2009 | US20090307806 Genetic markers for high oleic acid content in plants |
12/10/2009 | US20090307805 Alternative nucleotides for improved targeted nucleotide exchange |
12/10/2009 | US20090307798 Polynucleotides and Methods for Making Plants Resistant to Fungal Pathogens |
12/10/2009 | US20090307796 Plants with increased tolerance to water deficit |
12/10/2009 | US20090307794 Stress-Induced Transcription Factor Derived from Maize |
12/10/2009 | US20090307793 Plants expressing environmental stress tolerances having petunia cbf genes therein |
12/10/2009 | US20090307791 Calcium-activated chloride channel and methods of use thereof |
12/10/2009 | US20090307790 Isolation of the t-complex distorters and applications thereof |
12/10/2009 | US20090307788 Ribozyme mediated stabilization of polynucleotides |
12/10/2009 | US20090307181 Genetic analysis |
12/10/2009 | US20090306360 2-azaadenine bases form specific base pairs with guanine; when used to substitute cytosine in oligonucleotides leads specifically to hybridization complexes with nucleic acids with homogenous stability; 3-(2-Deoxy- beta -D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]purine (1,N6-Etheno-2'-deoxyadenosine, 5) |
12/10/2009 | US20090306359 Non-alcoholic buffer formulations for isolating, purifying and recovering long-chain and short-chain nucleic acids |
12/10/2009 | US20090306357 Compounds and methods for modulating expression of gccr |
12/10/2009 | US20090306356 siRNA Targeting TNFalpha |
12/10/2009 | US20090306342 Binding of molecules |
12/10/2009 | US20090306193 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer |
12/10/2009 | US20090306192 BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death |
12/10/2009 | US20090306189 Methods for Controlling Pests Using Rnai |
12/10/2009 | US20090306188 Importation of mitochondrial protein by an enhanced allotopic approach |
12/10/2009 | US20090306184 A composition comprising two double stranded nucleic acid molecules ; nucleic acids with a pyrimidine modification |
12/10/2009 | US20090306182 RNA INTERFERENCE MEDIATED INHIBITION OF MAP KINASE GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
12/10/2009 | US20090306180 Compounds and methods for modulating expression apob |
12/10/2009 | US20090306179 Compounds and methods for modulating expression of gcgr |
12/10/2009 | US20090306177 Modulation of Immunostimulatory Properties of Short Interfering Ribonucleic Acid (Sirna) by Nucleotide Modification |
12/10/2009 | US20090306010 P1-(2'-deoxycytidine 5'-)p4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salt, for treating disorders |
12/10/2009 | US20090306005 Compounds and methods for modulating expression of pcsk9 |
12/10/2009 | US20090305982 Muteins of tear lipocalin and methods for obtaining the same |
12/10/2009 | US20090305981 Secreted protein acidic and rich in cysteine (sparc) as chemotherapeutic sensitizers |
12/10/2009 | US20090305979 Compositions comprising hpv polypeptides and immunoenhancement peptides for the treatment and prevention of cervical cancer |
12/10/2009 | US20090305971 Nogo-B Receptor |
12/10/2009 | US20090305968 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
12/10/2009 | US20090305962 Low density lipoprotein receptor fusion for use in prevention and treatment of inflammation and autoimmune diseases |
12/10/2009 | US20090305961 Novel chimeric plasminogen activators and their pharmaceutical use |
12/10/2009 | US20090305950 Multimer of extracellular domain of cell surface functional molecule |
12/10/2009 | US20090305946 presenilin/G-protein/c-src binding polypeptides ; modulate the physiologic interactions of polypeptides required for the production of beta -amyloid (A beta ) |
12/10/2009 | US20090305900 Genemap of the human genes associated with longevity |
12/10/2009 | US20090305433 Water-Soluble Rhodamine Dye Conjugates |
12/10/2009 | US20090305420 Srsv detection kit |
12/10/2009 | US20090305419 Compositions for linking DNA-binding domains and cleavage domains |
12/10/2009 | US20090305410 Fluorescent compounds |
12/10/2009 | US20090305400 Modified chaperonin 10 |
12/10/2009 | US20090305399 for treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis |
12/10/2009 | US20090305394 Dna chip for diagnosis of corneal dystrophy |
12/10/2009 | US20090305383 Early Detection of Pathogens in Blood |
12/10/2009 | US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof |
12/10/2009 | US20090305359 Method for producing circular duplex polynucleotides from linear duplex polynucleotides and applications thereof |
12/10/2009 | US20090305353 Mutant firefly luciferase, gene, recombinant vector, transformant, and method for production of mutant firefly luciferase |
12/10/2009 | US20090305352 Activated collagen scaffold materials and their special fused active restoration factors |
12/10/2009 | US20090305351 Method for preparing soluble and active recombinant proteins using pdi as a fusion partner |
12/10/2009 | US20090305350 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
12/10/2009 | US20090305348 Diagnostic test for vitamin b12 |
12/10/2009 | US20090305346 Engineered cleavage half-domains |
12/10/2009 | US20090305345 Polymerase |
12/10/2009 | US20090305344 Chimeric alphavirus replicon particles |
12/10/2009 | US20090305343 Method For Expressing Polypeptides In Eukaryotic Cells Using Alternative Splicing |
12/10/2009 | US20090305341 HCL-K1 Polypeptide Which Offers Collectin Activity |
12/10/2009 | US20090305340 Altered peptide ligands of gad65 |
12/10/2009 | US20090305324 Cytotoxic t-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof |
12/10/2009 | US20090305309 Methods and Compositions for Detecting Neoplastic Cells |
12/10/2009 | US20090305281 Novel inhibitors of retroviral reverse transcriptace |
12/10/2009 | US20090305280 Luciferase biosensors for camp |
12/10/2009 | US20090305278 Sequence determination in confined regions |
12/10/2009 | US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES |
12/10/2009 | US20090305268 Method of determining an amount of fatty acid contents in bovine intramuscular fat on the basis of genotype of fatty acid synthase gene and method of determining goodness of eating quality of beef on the basis of the results thereof |
12/10/2009 | US20090305264 Cooperative probes and methods of using them |
12/10/2009 | US20090305263 Probe, probe set, probe-immobilized carrier, and genetic testing method |
12/10/2009 | US20090305262 Probe, probe set, probe-immobilized carrier, and genetic testing method |
12/10/2009 | US20090305261 Probe, probe set, probe-immobilized carrier, and genetic testing method |
12/10/2009 | US20090305260 Probe, probe set, probe-immobilized carrier, and genetic testing method |
12/10/2009 | US20090305252 Methods and species-specific primers for detection and quantification of Streptococcus mutans and Streptococcus sanguinis in mixed bacterial samples |
12/10/2009 | US20090305246 Schizophrenia associated genes and markers |
12/10/2009 | US20090305243 Oligonucleotides, Use Thereof, Detecting Method and Kit for Diagnosing the Presence of H5 and N1 Genes of the Influenza a Virus |
12/10/2009 | US20090305241 DNA demethylases and uses thereof |
12/10/2009 | US20090305235 Novel Targets For The Identification Of Antibiotics That Are Not Susceptible To Antibiotic Resistance |
12/10/2009 | US20090305234 Specific DNAS for Epigenetic Characterisation of Cells and Tissues |
12/10/2009 | US20090305233 Methods and Reagents for Polynucleotide Assembly |
12/10/2009 | US20090304901 Modulating plant protein levels |
12/10/2009 | US20090304858 Phosphoadenylyl Sulfate Reductase Gene and Use Thereof |
12/10/2009 | US20090304814 Fibrillation resistant proteins |
12/10/2009 | US20090304765 R-ras activity in vascular regulation |
12/10/2009 | US20090304752 Hypoallergenic variants of the major allergen from betula verrucosa pollen |
12/10/2009 | US20090304745 Chimeric alphavirus replicon particles |
12/10/2009 | US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera |
12/10/2009 | US20090304732 Cryptosporidium Hominis Genes and Gene Products for Chemotherapeutic, Immunoprophylactic and Diagnostic Applications |
12/10/2009 | US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof |
12/10/2009 | US20090304722 Chlamydia trachomatis antigens for vaccine and diagnostic use |
12/10/2009 | US20090304717 Immuno-RNA-Constructs |
12/10/2009 | US20090304713 Binding agents |
12/10/2009 | US20090304710 Novel anti-cd38 antibodies for the treatment of cancer |
12/10/2009 | US20090304693 Dual Variable Domain Immunoglobulins and Uses Thereof |
12/10/2009 | US20090304690 Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity |